Abstract

Envista Holdings will report fiscal results on February 05, 2026 Post Market; this preview outlines consensus expectations for revenue, margins, and adjusted EPS, reviews last quarter’s performance, highlights the outlook for core segments and the most promising business, and summarizes majority analyst sentiment and catalysts to watch.

Market Forecast

For the current quarter, the company-level forecast embedded in consensus points to revenue of $0.68 billion, up 5.32% year over year, with forecast adjusted EPS of $0.32 and EBIT of $0.09 billion; year-over-year forecast growth rates are 47.22% for adjusted EPS and 35.20% for EBIT. Management-margin proxies imply an outlook framed by a mid-50s gross margin and a net profit margin trending toward normalization from last quarter’s negative print, though explicit YoY margin guidance is unavailable. The main business mix remains anchored by Specialty Products & Technologies and Equipment & Consumables, with the former expected to sustain positive trends on product mix and recent launches. The most promising segment is Specialty Products & Technologies, with last quarter revenue of $0.43 billion; year-over-year growth for the segment this quarter is not disclosed, but the segment’s scale and mix are set to support incremental margin.

Last Quarter Review

Envista Holdings’ prior quarter delivered revenue of $0.67 billion, a gross profit margin of 55.99%, a GAAP net loss attributable to shareholders of $30.30 million with a net profit margin of -4.52%, and adjusted EPS of $0.32, with revenue growing 11.46% year over year and adjusted EPS rising 166.67% year over year. Quarter-on-quarter, net profit fell by 214.77%, reflecting exceptional or transition costs that overwhelmed operating gains despite a solid top-line and adjusted profitability beat. Main business highlights: Specialty Products & Technologies generated $0.43 billion, while Equipment & Consumables contributed $0.24 billion, with mix favoring higher-value technologies that supported the mid-50s gross margin level.

Current Quarter Outlook

Main business trajectory: sustaining mid-50s gross margin with mix support

The current quarter is set up around Envista Holdings’ two-pillar model of Specialty Products & Technologies alongside Equipment & Consumables. With Specialty Products & Technologies at $0.43 billion last quarter and comprising roughly two-thirds of revenue, mix should continue to underpin a gross margin profile around the mid-50s level in the company forecast. The expected $0.68 billion of revenue, up 5.32% year over year, suggests normalization after a double-digit growth quarter, with pricing and product launches likely to offset unit variability. Management’s operating cadence, evidenced by the prior quarter’s adjusted EPS of $0.32 versus consensus, supports the expectation of stable adjusted profitability even as reported net income transitions from a one-off-laden loss toward break-even or modest profit.

Most promising business: Specialty Products & Technologies as the incremental margin engine

Specialty Products & Technologies, at $0.43 billion last quarter, remains the primary vector for margin expansion and forecast EPS growth of 47.22% year over year. The qualitative setup implies that higher-value products and software-enabled workflows inside this segment can add operating leverage even on mid-single-digit consolidated revenue growth. If the segment sustains healthy order intake and pricing discipline, the combination of favorable mix and operating expense control can drive EBIT toward the forecast $0.09 billion, preserving upside risk to adjusted EPS should expenses track within plan. Over the medium term, segment innovation cadence and adoption rates will remain key determinants of quarterly variance.

Stock-price drivers this quarter: cadence of normalization, margin execution, and guidance tone

The market will likely key on whether GAAP net results normalize from the prior quarter’s loss and whether net margin returns to low-single-digit positive territory, consistent with the path implied by the forecasted EPS and EBIT growth rates. Any update to gross margin trajectory versus last quarter’s 55.99% will be scrutinized for sustainability, as modest pricing support and mix can offset cost inflation and FX headwinds. Guidance tone for the next quarter and full-year run-rate on adjusted EPS will carry outsized weight after the sequential net-income volatility; a reiteration or modest raise in revenue and EBIT outlooks would support the case for operating stabilization, while any reset could revive concerns about execution or macro sensitivity.

Analyst Opinions

Recent analyst commentary over the last six months skews Neutral-to-Cautious, with a majority of institutions maintaining Hold ratings while a minority remain constructive. Notable actions included an upgrade to Hold with a $24.00 price target from Mizuho Securities on December 20, 2025, alongside reiterated Hold stances from Jefferies and Leerink Partners through the fourth quarter of 2025, and a Hold view from William Blair citing valuation and macro considerations around November 29, 2025. Stifel Nicolaus, which remains on the more constructive side with a Buy and a $25.00 price target as of November 29, 2025, underscores that upside hinges on execution against product-led growth and operating leverage, yet this view is not the majority. The Hold-leaning consensus reflects a preference to see confirmation that adjusted profitability can translate into consistent GAAP earnings and that revenue growth at $0.68 billion with 5.32% year-over-year expansion can be sustained without sacrificing margin. Analysts emphasize that signs of normalized GAAP net income, stable mid-50s gross margin, and steady EPS conversion are prerequisites for a more favorable reassessment.